A case of G6PD Utrecht associated with β-thalassemia responding to splenectomy
Kun Yang1, Xiaodong Liu1, Kai Chen2
1Department of Hematology, Zigong First People's Hospital, Zigong, China.
Insights
Glucose-6-phosphate dehydrogenase (G6PD) deficiency caused chronic hemolytic anemia in a child. Genetic analysis identified a novel G6PD mutation, leading to transfusion independence after splenectomy.
Area of Science:
- Genetics
- Hematology
- Pediatrics
Background:
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common X-linked genetic disorder.
- Chronic nonspherocytic hemolytic anemia (CNSHA) is a severe manifestation requiring medical investigation.
- Genetic mutations in G6PD and HBB genes can lead to complex hematological conditions.
Observation:
- An 8-year-old Chinese male presented with CNSHA and hepatosplenomegaly.
- Genetic analysis revealed co-inheritance of a novel G6PD mutation (c.1225C>T, p.Pro409Ser) and a known HBB mutation (c.316-197C>T).
Findings:
- The G6PD c.1225C>T mutation, previously reported as G6PD Utrecht, was identified as the primary cause of the patient's hemolytic anemia.
- The co-inherited HBB mutation did not contribute significantly to the clinical phenotype.
- Splenectomy resulted in the patient achieving transfusion independence, indicating successful management of the anemia.
Implications:
- This case highlights the importance of comprehensive genetic analysis in diagnosing complex hematological disorders.
- The findings expand the known spectrum of G6PD mutations and their clinical presentations.
- Identifying the causative G6PD mutation guided therapeutic decisions, leading to improved patient outcomes.
Abstract:
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked genetic disease caused by a pathogenic G6PD mutation. An 8-year-old Chinese male child was investigated because of chronic nonspherocytic hemolytic anemia (CNSHA) associated with hepatosplenomegaly. Genetic analysis unraveled co-inheritance of a hemizygous mutation c.1225C>T (p.Pro409Ser) in G6PD (G6PD Utrecht, previously reported only in The Netherlands) and heterozygote HBB mutation c.316-197C>T (IVS-Ⅱ-654 C>T). Because IVS-Ⅱ-654 C>T on its own does not cause CNSHA, we believe that the clinical manifestations in this patient are essentially due to the G6PD c.1225C>T mutation. The boy gained transfusion independence after splenectomy.
More Related Videos
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...


